2021-03-29T12:48:51Z
2021-03-29T12:48:51Z
2021-01-29
2021-03-29T12:48:51Z
Biased signaling is a concept that has arisen in the G protein-coupled receptor (GCPR) research field, and holds promise for the development of new drug development strategies. It consists of different signaling outputs depending on the agonist's chemical structure. Here we review the most accepted mechanisms for explaining biased agonism, namely the induced fit hypothesis and the key/lock hypothesis, but we also consider how bias can be produced by a given agonist. In fact, different signaling outputs may originate at a given receptor when activated by, for instance, the endogenous agonist. We take advantage of results obtained with adenosine receptors to explain how such mechanism of functional selectivity depends on the context, being receptor-receptor interactions (heteromerization) one of the most relevant and most studied mechanisms for mammalian homeostasis. Considering all the possible mechanisms underlying functional selectivity is essential to optimize the selection of biased agonists in the design of drugs targeting GPCRs.
Article
Published version
English
Desenvolupament de medicaments; Receptors de medicaments; Proteïnes; Drug development; Drug receptors; Proteins
Frontiers Media
Reproducció del document publicat a: https://doi.org/10.3389/fphar.2020.628601
Frontiers in Pharmacology, 2021, vol. 11
https://doi.org/10.3389/fphar.2020.628601
cc-by (c) Franco Fernández, Rafael et al., 2021
http://creativecommons.org/licenses/by/3.0/es